About Cherry Thomas
Cherry Thomas is a chief medical officer at Allotera Therapeutics.
Experience
This experience comes from Cherry Thomas's profile and from SEC filings. For roles taken from filings, the years are when the filings name Cherry Thomas in the role, so the role may have started earlier or lasted longer.
Allotera Therapeutics, Inc. Current
Chief Medical Officer
2024 – Present · St. Louis, MO
Develops donor-cell therapies for people with blood cancers.
CB
Catamaran Bio
Chief Medical Officer
2022 – 2024
CB
Caribou Biosciences
Senior Vice President of Clinical Development
2020 – 2022
AI
Array BioPharma Inc.
Vice President, Oncology Clinical Development
2018 – 2020
BE
BeiGene
Executive Director, Clinical Development
2017 – 2018
BD
Bristol-Myers Squibb, Oncology Clinical Development
Group Director, Immuno-Oncology, Oncology Clinical Development
2014 – 2017
NO
Novartis
Medical Director and Regional Head of Solid Tumor Oncology, Latin America and Canada
2010 – 2014
AM
Amgen
Medical Director
2006 – 2008
UU
UCSD | UCLA
Assistant Professor, Radiation Oncology
2004 – 2006
Key Colleagues at Startups
The people Cherry Thomas works with at each company, as listed on that company's latest Form D.
Allotera Therapeutics, Inc. · Form D/A, Jul 23, 2026
DD
Drew Dennison
Director
KL
Kevin Li
Director
NM
Natalie Mount
Director
ND
Niall O'Donnell
Director
Kumar Srinivasan
President & Chief Executive Officer, director
Matthew Cooper
Co-Founder & Chief Scientific Officer
BH
Bosun Hau
Director
PK
Peter Kiener
Chair
Ayman Kabakibi
Chief Operating Officer & EVP, R&D
BM
Bali Muralidhar
Director